Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation.

× No keyword cloud information.

12 in total

1. Tigecycline treatment of urinary tract infection and prostatitis: case report and literature review.

Authors: Duane Bates; Mike Parkins; Robin Hellweg; Kimberly Gibson; Jennifer M Bugar
Journal: Can J Hosp Pharm Date: 2012-05

Review 2. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors: Magnus Unemo; William M Shafer
Journal: Clin Microbiol Rev Date: 2014-07 Impact factor: 26.132

Review 3. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Authors: Magnus Unemo; Robert A Nicholas
Journal: Future Microbiol Date: 2012-12 Impact factor: 3.165

Review 4. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes.

Authors: David van Duin; Keith S Kaye; Elizabeth A Neuner; Robert A Bonomo
Journal: Diagn Microbiol Infect Dis Date: 2013-01-03 Impact factor: 2.803

5. Treatment of resistant enterococcal urinary tract infections.

Authors: Subramanian Swaminathan; George J Alangaden
Journal: Curr Infect Dis Rep Date: 2010-11 Impact factor: 3.725

6. Treatment and clinical outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort.

Authors: Bryan T Alexander; Jonas Marschall; Robert J Tibbetts; Elizabeth A Neuner; W Michael Dunne; David J Ritchie
Journal: Clin Ther Date: 2012-06 Impact factor: 3.393

Review 7. Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review.

Authors: Andrew Chou; Elwyn Welch; Andrew Hunter; Barbara W Trautner
Journal: Drugs Date: 2022-03-14 Impact factor: 11.431

Review 8. Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.

Authors: J Alexander Viehman; M Hong Nguyen; Yohei Doi
Journal: Drugs Date: 2014-08 Impact factor: 9.546

9. Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms.

Authors: Elizabeth A Neuner; Jennifer Sekeres; Gerri S Hall; David van Duin
Journal: Antimicrob Agents Chemother Date: 2012-08-27 Impact factor: 5.191

Review 10. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.

Authors: Magnus Unemo
Journal: BMC Infect Dis Date: 2015-08-21 Impact factor: 3.090